Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.
about
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyHAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.Oncolytic immunotherapy: where are we clinically?Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors.Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs.Antiviral activity of cationic amphiphilic drugs.Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compoundAdenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy.In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders.Anti-Viral Drugs for Human Adenoviruses.
P2860
Q30899557-2D2169F9-B560-470D-A5AE-E53A492414CEQ32183133-0B58282B-3357-47D1-9A06-75FE2E03716BQ33711997-A0B07FD3-8D30-4A66-8E42-7739F406C24AQ34205181-D8126F56-312E-4BC9-9960-167CF64DA8F8Q34405325-1196EB04-56AB-40D6-83E8-1B8065EA39F3Q35238258-AEB2260B-5373-4064-A9D7-B4CC37B62DB7Q37185367-671C8A79-7822-43EA-BD56-512679280BF7Q38893420-5D38C28A-4C31-450E-8A40-68E8579388FDQ39135464-690C0850-3224-43B6-B7F7-C02043689564Q39175768-5A7FC270-9085-44CC-81A9-D7F72A1C75BDQ39687396-4FA6CC76-F5F0-4E06-9618-078D7C7F2D59Q41963078-BD00F571-888B-4F85-8C5F-78E6AC35FF2EQ42254679-34D1EDE3-CF30-4274-B1DF-CAD351DBE6C1Q46103262-E4AA1784-333B-43E4-88C1-B00E519BB5DC
P2860
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@en
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@nl
type
label
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@en
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@nl
prefLabel
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@en
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@nl
P2093
P2860
P50
P356
P1476
Human adenovirus replication i ...... h chlorpromazine or cidofovir.
@en
P2093
Gerd J Bauerschmitz
Ruben Hernandez-Alcoceba
Sari Pesonen
P2860
P304
P356
10.1002/JGM.1453
P577
2010-05-01T00:00:00Z